Vet Custom Label (VCL), a leading developer of veterinary nutraceuticals, has announced the acquisition of the well-established Myristol brand of joint-support formulations for horses, dogs, cats, and rabbits, marking a strategic move to strengthen its presence in science-based animal supplements.
Myristol is well known for its evidence-based approach to joint health in both performance animals and companion pets, and it has more than 20 years of industry credibility. Myristol’s formulas will not change as a result of the acquisition, guaranteeing ongoing availability, efficacy, and consistency for clients and veterinary partners.
Dr. Gayle Trotter, the founder of Myristol, will continue to assist the company in a consulting capacity during the transition, providing continuing knowledge in formulation development, quality assurance, and technical advice to guarantee smooth continuity.
“Animal-care professionals trust Myristol for consistent results,” said David Levy, Managing Member of Vet Custom Label. “We are committed to preserving that trust while expanding Myristol’s reach and securing its legacy for the future.”
Dr. Trotter emphasized the importance of choosing the right partner to carry the brand forward. “The relationships we’ve built and the stories of how Myristol has helped animals thrive mean everything to us,” she said. “Vet Custom Label shares our commitment to quality, integrity, and animal well-being, and I am confident customers will continue to receive the excellence they expect.”
The acquisition supports VCL’s overarching goal of providing veterinary professionals with high-quality, evidence-based supplements while guaranteeing clients that Myristol’s reliable standards and product availability would continue.